Point72 Asia (Singapore) Pte. Ltd. Pmv Pharmaceuticals, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 32,603 shares of PMVP stock, worth $41,405. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,603
Previous 32,190
1.28%
Holding current value
$41,405
Previous $48 Million
2.64%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding PMVP
# of Institutions
78Shares Held
41.8MCall Options Held
500Put Options Held
500-
Orbimed Advisors LLC San Diego, CA6.48MShares$8.22 Million0.26% of portfolio
-
Sio Capital Management, LLC New York, NY3.57MShares$4.54 Million2.01% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.51MShares$4.46 Million0.08% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.47MShares$4.4 Million3.25% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.34 Million0.54% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $57.9M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...